GPRC5D-Targeted CAR T Cells for Myeloma. Reply

N Engl J Med. 2022 Dec 15;387(24):2296. doi: 10.1056/NEJMc2213985.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Immunotherapy, Adoptive
  • Multiple Myeloma* / therapy
  • Receptors, Chimeric Antigen*
  • Receptors, G-Protein-Coupled
  • T-Lymphocytes

Substances

  • Receptors, Chimeric Antigen
  • GPRC5D protein, human
  • Receptors, G-Protein-Coupled